Although directly testing this hypothesis was beyond the scope of the current study, evidence suggests that decreased promoter activity and protein stability associated susceptibility to HCC, suggesting that SERPINB5 downregulation is associated with increase susceptibility to HCC. This evidence concerns the gene SERPINB5 and hepatocellular carcinoma.